We believe there is now sufficient evidence to recommend that women with locally advanced cervical cancer confined to the pelvis receive pelvic radiation concomitantly with treatment with cisplatin and fluorouracil .
In 1990 , the Radiation Therapy Oncology Group (RTOG) began a randomized clinical trial to compare the effects on survival of treatment with extended-field radiation and treatment with pelvic radiotherapy and concurrent chemotherapy in patients with cervical cancer .
